91 related articles for article (PubMed ID: 11131676)
21. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
22. Expression of p53 and p21 in primary glioblastomas.
Gross MW; Kraus A; Nashwan K; Mennel HD; Engenhart-Cabillic R; Schlegel J
Strahlenther Onkol; 2005 Mar; 181(3):164-71. PubMed ID: 15756520
[TBL] [Abstract][Full Text] [Related]
23. Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo.
Said HM; Stein S; Hagemann C; Polat B; Staab A; Anacker J; Schoemig B; Theobald M; Flentje M; Vordermark D
Oncol Rep; 2009 Jan; 21(1):237-46. PubMed ID: 19082468
[TBL] [Abstract][Full Text] [Related]
24. High mobility group A1 expression correlates with the histological grade of human glial tumors.
Donato G; Martinez Hoyos J; Amorosi A; Maltese L; Lavano A; Volpentesta G; Signorelli F; Pentimalli F; Pallante P; Ferraro G; Tucci L; Signorelli CD; Viglietto G; Fusco A
Oncol Rep; 2004 Jun; 11(6):1209-13. PubMed ID: 15138557
[TBL] [Abstract][Full Text] [Related]
25. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme.
Chang CY; Li MC; Liao SL; Huang YL; Shen CC; Pan HC
J Clin Neurosci; 2005 Nov; 12(8):930-3. PubMed ID: 16326273
[TBL] [Abstract][Full Text] [Related]
26. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
27. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
[TBL] [Abstract][Full Text] [Related]
28. Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasms.
Braczkowski R; Zubelewicz B; Romanowski W; Lissoni P; Brivio F
J Exp Clin Cancer Res; 1998 Sep; 17(3):349-54. PubMed ID: 9894774
[TBL] [Abstract][Full Text] [Related]
29. Effect of recombinant human TNF-binding protein-1 and GnRH antagonist on mRNA expression of inflammatory cytokines and adhesion and growth factors in endometrium and endometriosis tissues in baboons.
Kyama CM; Overbergh L; Mihalyi A; Cuneo S; Chai D; Debrock S; Mwenda JM; Mathieu C; Nugent NP; D'Hooghe TM
Fertil Steril; 2008 May; 89(5 Suppl):1306-13. PubMed ID: 18061171
[TBL] [Abstract][Full Text] [Related]
30. Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic Stapes footplates in connection with measles virus positivity.
Karosi T; Jókay I; Kónya J; Szabó LZ; Pytel J; Jóri J; Szalmás A; Sziklai I
Laryngoscope; 2006 Aug; 116(8):1427-33. PubMed ID: 16885748
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of serpin squamous cell carcinoma antigen 2 in human tumor tissues and cell lines: evidence of protection from tumor necrosis factor-mediated apoptosis.
Takeda A; Kajiya A; Iwasawa A; Nakamura Y; Hibino T
Biol Chem; 2002; 383(7-8):1231-6. PubMed ID: 12437110
[TBL] [Abstract][Full Text] [Related]
32. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
34. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK
Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427
[TBL] [Abstract][Full Text] [Related]
35. Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells.
Tandle AT; Mazzanti C; Alexander HR; Roberts DD; Libutti SK
Cytokine; 2005 Jun; 30(6):347-58. PubMed ID: 15935955
[TBL] [Abstract][Full Text] [Related]
36. Effect of TNF-alpha on human osteosarcoma cell line Saos2--TNF-alpha regulation of bone sialoprotein gene expression in Saos2 osteoblast-like cells.
Nakayama Y; Kato N; Nakajima Y; Shimizu E; Ogata Y
Cell Biol Int; 2004; 28(10):653-60. PubMed ID: 15516323
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
39. A soluble 17 kDa tumour necrosis factor (TNF) mutein, TNF-SAM2, with membrane-bound TNF-like biological characteristics.
Yoshida A; Kohchi C; Inagawa H; Nishizawa T; Hori H; Soma G
Anticancer Res; 2006; 26(6A):4003-7. PubMed ID: 17195449
[TBL] [Abstract][Full Text] [Related]
40. The influence of antimalarial treatment on IL-1beta, IL-6 and TNF-alpha mRNA expression on UVB-irradiated skin in systemic lupus erythematosus.
Wozniacka A; Lesiak A; Boncela J; Smolarczyk K; McCauliffe DP; Sysa-Jedrzejowska A
Br J Dermatol; 2008 Nov; 159(5):1124-30. PubMed ID: 18764842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
